Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  zirconium Zr 89 trastuzumab
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-6 of 6 for your search:
Start Over
IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Phase: Phase II, Phase I
Type: Diagnostic, Health services research
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: IMPACT MBC, NCT01957332
Clinical Value of 89Zr-trastuzumab PET
Phase: Phase II
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: Her2.4, NCT01832051
Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IJBMNZrT003, NCT01420146
PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Phase: No phase specified
Type: Diagnostic, Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-165, NCT02023996
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201307037, R21CA182945, NCT02065609
Can HER2 Targeted 89Zr-trastuzumab PET/CT Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 14-156, NCT02286843
Start Over